Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Showing 1 to 24 of 24

TitleReference numberPublishedLast updated
Rare diseasesQS214
Hypertension in adults: diagnosis and managementNG136
Blood transfusionNG24
Blood transfusionQS138
Nirmatrelvir plus ritonavir and tocilizumab for treating COVID-19TA878
Molnupiravir for treating COVID-19TA1056
Bevacizumab (originator and biosimilars) with fluoropyrimidine-based chemotherapy for metastatic colorectal cancerTA1136
Canagliflozin for treating type 2 diabetes in people 10 to 17 years (terminated appraisal)TA1137
Leadless cardiac pacemaker implantation for bradyarrhythmiasHTG770
Transcatheter tricuspid valve implantation for symptomatic severe tricuspid regurgitationHTG771
Baloxavir marboxil for treating and preventing influenza in children 1 to 11 years (terminated appraisal)TA1135
Belantamab mafodotin with pomalidomide and dexamethasone for previously treated multiple myelomaTA1133
Dupilumab for treating severe chronic rhinosinusitis with nasal polypsTA1134
Type 2 diabetes in adults: managementNG28
Type 2 diabetes in adultsQS209
Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2HST34
Ruxolitinib for treating moderate to severe chronic graft versus host disease after an allogeneic stem cell transplant in people 28 days to 17 years (terminated appraisal)TA1132
Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapyTA1129
Obinutuzumab with mycophenolate mofetil for treating lupus nephritisTA1131
Talazoparib with enzalutamide for untreated hormone-relapsed metastatic prostate cancerTA1130
Pulmonary artery pressure technologies for remote monitoring of chronic heart failureHTG769
Nivolumab with chemotherapy for neoadjuvant treatment then alone for adjuvant treatment of resectable non-small-cell lung cancerTA1127
Targeted-release budesonide for treating primary IgA nephropathyTA1128
Digital technologies to support self-management of COPD: early value assessmentHTG736

Results per page

  1. 10
  2. 25
  3. 50
  4. All